NervGen Pharma (NGENF) Short Interest Ratio & Short Volume → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free NGENF Stock Alerts $1.53 +0.04 (+2.69%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest NervGen Pharma Short Interest DataCurrent Short Volume68,900 sharesPrevious Short Volume416,300 sharesChange Vs. Previous Month-83.45%Dollar Volume Sold Short$103,350.00Short Interest Ratio / Days to Cover0.6Last Record DateApril 15, 2024Outstanding Shares61,770,000 sharesPercentage of Shares Shorted0.11%Today's Trading Volume2,140 sharesAverage Trading Volume68,711 sharesToday's Volume Vs. Average3% Short Selling NervGen Pharma ? Sign up to receive the latest short interest report for NervGen Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNGENF Short Interest Over TimeNGENF Days to Cover Over TimeNGENF Percentage of Float Shorted Over Time Ad InvestorPlaceProof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…Go here now for full story. NervGen Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202468,900 shares $103,350.00 -83.5%N/A0.6 $1.50 3/31/2024416,300 shares $670,243.00 +67.8%N/A1.3 $1.61 3/15/2024248,100 shares $474,069.48 +151.4%N/A2.3 $1.91 2/29/202498,700 shares $251,685.00 +296.4%N/A0.9 $2.55 2/15/202424,900 shares $63,412.83 +38.3%N/A0.1 $2.55 1/15/202444,600 shares $88,085.00 -1.8%N/A0.3 $1.98 Get the Latest News and Ratings for NGENF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NervGen Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/202345,400 shares $92,616.00 +1,791.7%N/A0.2 $2.04 12/15/20232,400 shares $2,955.60 +700.0%N/A0 $1.23 11/30/2023300 shares $393.00 -96.0%N/A0 $1.31 11/15/20237,400 shares $10,567.20 +13.9%N/A0.1 $1.43 10/31/20236,500 shares $8,710.00 +333.3%N/A0.1 $1.34 10/15/20231,500 shares $1,943.40 -81.9%N/A0 $1.30 9/30/20238,300 shares $11,715.45 +6.4%N/A0.2 $1.41 9/15/20237,800 shares $11,934.00 -57.1%N/A0.1 $1.53 8/31/202318,200 shares $27,614.86 +237.0%N/A0.2 $1.52 8/15/20235,400 shares $7,162.02 -79.6%N/A0.1 $1.33 7/31/202326,500 shares $34,185.00 +6.4%N/A1 $1.29 7/15/202324,900 shares $32,619.00 -2.7%N/A0.8 $1.31 6/30/202325,600 shares $31,744.00 -20.0%N/A0.4 $1.24 6/15/202332,000 shares $41,600.00 -32.9%N/A1.2 $1.30 5/31/202347,700 shares $62,010.00 +166.5%N/A1.1 $1.30 5/15/202317,900 shares $20,943.00 +96.7%N/A0.4 $1.17 4/30/20239,100 shares $10,556.00 -50.5%N/A0.1 $1.16 4/15/202318,400 shares $24,381.84 +318.2%N/A0.4 $1.33 3/31/20234,400 shares $5,425.20 +7.3%N/A0.1 $1.23 3/15/20234,100 shares $5,104.50 -33.9%N/A0.1 $1.25 2/28/20236,200 shares $8,556.00 +463.6%N/A0.1 $1.38 2/15/20231,100 shares $1,606.00 -38.9%N/A0 $1.46 1/31/20231,800 shares $2,907.00 +200.0%N/A0 $1.62 1/15/2023600 shares $864.00 -83.8%N/A0 $1.44 12/30/20223,700 shares $4,403.00 +516.7%N/A0.1 $1.19 12/15/2022600 shares $720.00 -81.8%N/A0 $1.20 11/30/20223,300 shares $4,686.00 -13.2%N/A0.1 $1.42 11/15/20223,800 shares $4,959.00 +111.1%N/A0.1 $1.31 10/31/20221,800 shares $2,358.00 -56.1%N/A0.1 $1.31 10/15/20224,100 shares $5,084.00 -73.6%N/A0.1 $1.24 9/30/202215,500 shares $20,770.00 +453.6%N/A0.2 $1.34 9/15/20222,800 shares $4,125.24 -42.9%N/A0.1 $1.47 8/31/20224,900 shares $7,399.00 No ChangeN/A0.1 $1.51 7/31/202210,500 shares $17,640.00 -34.4%N/A0.1 $1.68Gold Set to EXPLODE! (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! NGENF Short Interest - Frequently Asked Questions What is NervGen Pharma's current short interest? Short interest is the volume of NervGen Pharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 68,900 shares of NGENF short. Learn More on NervGen Pharma's current short interest. What is a good short interest ratio for NervGen Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NGENF shares currently have a short interest ratio of 1.0. Learn More on NervGen Pharma's short interest ratio. Is NervGen Pharma's short interest increasing or decreasing? NervGen Pharma saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 68,900 shares, a drop of 83.4% from the previous total of 416,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does NervGen Pharma's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to NervGen Pharma: LianBio (0.36%), Milestone Pharmaceuticals Inc. (0.81%), Spectral Medical Inc. (0.02%), AlloVir, Inc. (5.57%), ProPhase Labs, Inc. (1.95%), Anixa Biosciences, Inc. (1.82%), Oncolytics Biotech Inc. (1.23%), Spero Therapeutics, Inc. (0.95%), Vivani Medical, Inc. (1.97%), Curis, Inc. (1.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short NervGen Pharma stock? Short selling NGENF is an investing strategy that aims to generate trading profit from NervGen Pharma as its price is falling. NGENF shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NervGen Pharma? A short squeeze for NervGen Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NGENF, which in turn drives the price of the stock up even further. How often is NervGen Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NGENF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: LianBio Short Interest Data Milestone Pharmaceuticals Short Interest Data Spectral Medical Short Interest Data AlloVir Short Interest Data ProPhase Labs Short Interest Data Anixa Biosciences Short Interest Data Oncolytics Biotech Short Interest Data Spero Therapeutics Short Interest Data Vivani Medical Short Interest Data Curis Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NGENF) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 Media